Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQB - Delayed Quote USD

Hemostemix Inc. (HMTXF)

0.0640
0.0000
(0.00%)
At close: April 24 at 4:00:00 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
2,015.0930
2,156.9680
4,578.0110
6,655.8220
7,466.3540
Operating Income
-2,015.0930
-2,156.9680
-4,578.0110
-6,655.8220
-7,466.3540
Net Non Operating Interest Income Expense
-598.2860
-556.1180
-354.0180
-20.8520
-113.0340
Other Income Expense
53.9540
210.9770
183.4760
135.1690
-189.1090
Pretax Income
-2,559.4250
-2,502.1090
-4,748.5530
-6,541.5050
-7,768.4970
Tax Provision
--
--
486.9210
-255.7840
--
Net Income Common Stockholders
-2,559.4250
-2,502.1090
-5,235.4740
-6,285.7210
-7,768.4970
Diluted NI Available to Com Stockholders
-2,559.4250
-2,502.1090
-5,235.4740
-6,285.7210
-7,768.4970
Basic EPS
-0.03
-0.03
-0.07
-0.11
-0.24
Diluted EPS
-0.03
-0.03
-0.07
-0.11
-0.24
Basic Average Shares
84,457.5860
82,499.1890
69,981.2960
57,449.8730
32,240.5720
Diluted Average Shares
84,457.5860
82,499.1890
69,981.2960
57,449.8730
32,240.5720
Rent Expense Supplemental
--
--
--
--
288.4070
Total Expenses
2,015.0930
2,156.9680
4,578.0110
6,655.8220
7,466.3540
Net Income from Continuing & Discontinued Operation
-2,559.4250
-2,502.1090
-5,235.4740
-6,285.7210
-7,768.4970
Normalized Income
-2,851.1340
-2,713.0860
-5,370.8609
-6,415.6047
-7,579.3880
Interest Income
--
--
--
73.0600
--
Interest Expense
601.7490
550.0840
350.3140
10.4870
106.0490
Net Interest Income
-598.2860
-556.1180
-354.0180
-20.8520
-113.0340
EBIT
-1,957.6760
-1,952.0250
-4,398.2390
-6,531.0180
-7,662.4480
EBITDA
-1,957.4830
-1,951.8020
-4,397.7440
-6,529.9170
-7,660
Reconciled Depreciation
0.1310
0.2230
0.4950
1.1010
2.4480
Net Income from Continuing Operation Net Minority Interest
-2,559.4250
-2,502.1090
-5,235.4740
-6,285.7210
-7,768.4970
Total Unusual Items Excluding Goodwill
291.7090
210.9770
183.4760
135.1690
-189.1090
Total Unusual Items
291.7090
210.9770
183.4760
135.1690
-189.1090
Normalized EBITDA
-2,249.1920
-2,162.7790
-4,581.2200
-6,665.0860
-7,470.8910
Tax Rate for Calcs
--
--
0.0003
0
--
Tax Effect of Unusual Items
--
--
48.0891
5.2853
--
12/31/2020 - 1/7/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RENB Renovaro Inc.
0.3728
-0.75%
 
ONC BeiGene, Ltd.
256.16
+2.82%
 
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.9000
+4.32%
 
APLT Applied Therapeutics, Inc.
0.3983
+7.65%
 
BMEA Biomea Fusion, Inc.
2.3000
+11.65%
 
BHVN Biohaven Ltd.
23.40
+9.24%
 
GERN Geron Corporation
1.4200
+2.16%
 
REGN Regeneron Pharmaceuticals, Inc.
599.76
+2.03%
 
VRTX Vertex Pharmaceuticals Incorporated
492.47
+0.01%
 
MRNA Moderna, Inc.
27.39
+3.20%